Bayamban, Eto H.

HRN: 22-57-27  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/07/2025
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
05/07/2025
05/13/2025
IV
4.5g
Q8H
Complicated UTI (Yeast)
Waiting Final Action 

Indication:  Empirical De-escalation    Type of Infection:  Urinary Tract    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Final appropriateness: Yes   

Overall appropriateness: Yes 

Intervention



Type of Intervention done:

                    

           


Acceptance: